22nd Century Group

22nd Century Group is a leading plant biotechnology company focused on technologies that alter the level of nicotine in tobacco plants and the level of cannabinoids in hemp/cannabis plants through genetic engineering, gene-editing and modern plant breeding.
22nd Century Group stock price chart
vol.
change
P/E
Net profit
P/B
Book value
P/FCF
FCF
Yield
Growth potential

22nd Century Group balance sheet

Report period2018 2019 2020 2021 2022Q3 23
End date of the reporting period
Capitalization, $
Capitalization, $
Enterprise Value
Book Value
Shareholders Book Value
Current liabilities
Noncurrent liabilities
Total liabilities
Debt
Cash and cash equivalents
Net debt
Assets
Total ordinary shares
Ordinary share price

22nd Century Group cash flows

Report period2018 2019 2020 2021 2022Q3 23 TTM
End date of the reporting period
Sales
Gross profit
Operation Income
Earnings
Shareholders earnings
EBITDA
Adjusted EBITDA
Operation Cashflow
Capital expenditure
Free Cash Flow
EPS

22nd Century Group multipliers

Report period2018 2019 2020 2021 2022Q3 23 TTM
P/E
E/P
P/B
P/S
P/FCF
L/A
Debt-To-Equity
Net Debt/EBITDA
Net Debt/EBITDA adj.
EV/EBITDA
EV/EBITDA adj.

22nd Century Group profitability

Report period2018 2019 2020 2021 2022Q3 23 TTM
ROA
ROE
ROS
Gross margin
EBITDA Margin
Operating margin
22nd Century Group assets
22nd Century Group cash flows

22nd Century Group shares

TickerNameTypeNominal valueISINPrice
XXII:US22nd Century GroupCommon share-US90137F1030$0.118
22nd Century Group news
05.05.2022
22nd Century Group's GAAP loss for 3 months of 2022 was $8.918 million, up 77.3% from $5.03 million in the prior year. Revenue increased 32.9% to $9.045 million from $6.806 million a year earlier.
Source: {source} pictogram xxiicentury.com
Pictogram next
01.03.2022
22nd Century Group's GAAP loss for 2021 was $32.609 million, up 65.4% from $19.711 million in the prior year. Revenue increased 10.1% to $30.948 million from $28.111 million a year earlier.
Source: {source} pictogram xxiicentury.com
Pictogram next
24.12.2021
22nd Century Group has received FDA approval to sell VLN King and VLN Menthol King reduced nicotine cigarettes. This line tastes and smells like regular cigarettes, but contains 95% less nicotine.
Source: {source} pictogram xxiicentury.com
Pictogram next
04.11.2021
22nd Century Group's GAAP loss for 9M 2021 was $18.644 million, up 40.1% from $13.307 million in the prior year. Revenue increased 10.5% to $22.988 million from $20.803 million a year earlier.
Source: {source} pictogram xxiicentury.com
Pictogram next
All 22nd Century Group news
General information
Company name22nd Century Group
SectorConsumer Staples / Food, Beverage & Tobacco / Tobacco / Tobacco
Websitewww.xxiicentury.com